ATNF 180 Life Sciences Corp
- Stocks
- Healthcare
- NASDAQ: ATNF
Price (delayed)
$2.64
Market cap
$15.94M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$15.07
Enterprise value
$15.14M
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined
Highlights
The quick ratio has dropped by 55% since the previous quarter but it has increased by 45% year-on-year
180 Life Sciences's net income has increased by 27% YoY but it has decreased by 23% QoQ
180 Life Sciences's equity has decreased by 30% from the previous quarter
Key stats
What are the main financial stats of ATNF
Market
Valuations
Earnings
Shares outstanding
6.04M
Market cap
$15.94M
Enterprise value
$15.14M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.79
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$6.49M
Net income
-$9.21M
EBIT
-$9.47M
EBITDA
-$9.46M
Free cash flow
-$3.16M
Per share
Balance sheet
Liquidity
EPS
-$15.07
EPS diluted
-$15.07
Free cash flow per share
-$0.55
Book value per share
$0.94
Revenue per share
$0
TBVPS
$0.54
Total assets
$10.71M
Total liabilities
$5.33M
Debt
$1.41M
Equity
$5.38M
Working capital
-$2.24M
Debt to equity
0.26
Current ratio
0.58
Quick ratio
0.42
Net debt/EBITDA
0.09
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-151%
Return on equity
-264.2%
Return on invested capital
N/A
Return on capital employed
-176.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATNF stock price
How has the 180 Life Sciences stock price performed over time
Intraday
23.94%
1 week
40.43%
1 month
200.07%
1 year
14.78%
YTD
45.05%
QTD
184.42%
Financial performance
How have 180 Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.49M
Net income
-$9.21M
Gross margin
N/A
Net margin
N/A
180 Life Sciences's operating income has increased by 27% YoY
180 Life Sciences's net income has increased by 27% YoY but it has decreased by 23% QoQ
Price vs fundamentals
How does ATNF's price correlate with its fundamentals
Growth
What is 180 Life Sciences's growth rate over time
Valuation
What is 180 Life Sciences stock price valuation
P/E
N/A
P/B
2.79
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ATNF's EPS is up by 6% year-on-year but it is down by 2.1% since the previous quarter
The price to book (P/B) is 65% lower than the 5-year quarterly average of 6.4
180 Life Sciences's equity has decreased by 30% from the previous quarter
Efficiency
How efficient is 180 Life Sciences business performance
The company's return on assets rose by 47% YoY and by 5% QoQ
180 Life Sciences's return on equity has increased by 13% QoQ
Dividends
What is ATNF's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATNF.
Financial health
How did 180 Life Sciences financials performed over time
The company's total assets is 101% higher than its total liabilities
The company's total assets has surged by 174% YoY but it fell by 8% QoQ
The quick ratio has dropped by 55% since the previous quarter but it has increased by 45% year-on-year
ATNF's debt is 74% smaller than its equity
ATNF's debt to equity has soared by 125% year-on-year
180 Life Sciences's equity has decreased by 30% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.